Procter & Gamble Health standalone net profit declines 43.73% in the June 2024 quarter

Net profit of Procter & Gamble Health declined 43.73% to Rs 16.78 crore in the quarter ended June 2024 as against Rs 29.82 crore during the previous quarter ended June 2023. Sales declined 5.74% to Rs 283.88 crore in the quarter ended June 2024 as against Rs 301.18 crore during the previous quarter ended June 2023.

For the full year,net profit declined 12.42% to Rs 200.98 crore in the year ended June 2024 as against Rs 229.47 crore during the previous year ended June 2023. Sales declined 6.37% to Rs 1151.26 crore in the year ended June 2024 as against Rs 1229.62 crore during the previous year ended June 2023.

Particulars	Quarter Ended			Year Ended
	Jun. 2024	Jun. 2023	% Var.	Jun. 2024	Jun. 2023	% Var.
Sales	283.88	301.18	-6	1151.26	1229.62	-6
OPM %	17.00	15.05	-	26.58	26.40	-
PBDT	50.18	50.63	-1	320.91	342.30	-6
PBT	43.02	44.13	-3	293.51	314.20	-7
NP	16.78	29.82	-44	200.98	229.47	-12